Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT treatment = Holy-grail of oncologists

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Aug 31, 2023 12:00pm

161 Views

Post# 35613958

RE:RE:RE:RE:TLT treatment = Holy-grail of oncologists

That's the plan, according to Roger in his recent interview:

"Theralase® is currently working on completing the pre-clinical work that will allow commencement of a Phase Ib/II clinical study focused on glioblastoma multiforme, a deadly form of brain cancer, in early 2024."

Galaxym31 wrote: Why not try on brain cancer victims , survival for GBM is around 8 months and not a good 8 months .We are talking about 100 % fatal , 7 years ago they ran the stock up on petri dish results on GBM .

<< Previous

Bullboard Posts

Next >>

AI companies to invest in